MLYS

Mineralys Therapeutics, Inc.

Pharmaceutical Preparations · SIC 2834CIK 1933414Held by 6 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

6 managers · Q2 2026 13F

13F bookWeight

RA Capital Management

RA Capital ManagementPosition history →

1.8%

—

$207.6M

$11.51B13F book · 2026-06-30

Deerfield Management Company

Deerfield Management CompanyPosition history →

1.1%

NEW

$106.8M

$9.59B13F book · 2026-06-30

OrbiMed Advisors

OrbiMed AdvisorsPosition history →

1.1%

+2.8%

$56.9M

$5.25B13F book · 2026-06-30

Suvretta Capital Management

Suvretta Capital ManagementPosition history →

0.10%

(88.7%)

$4.7M

$4.76B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

0.01%

+38.1%

$2.4M

$21.33B13F book · 2026-06-30

Capital World Investors

Capital World InvestorsPosition history →

0.01%

+401.7%

$53.9M

$846.43B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.